Literature DB >> 17152926

Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.

S Azzouz1, M Maache, M F Dos Santos, M E Sarciron, A F Petavy, A Osuna.   

Abstract

To discover the mode of action of alkyl-lysophospholipids in Leishmania donovani, we studied the effects of edelfosine, miltefosine, and ilmofosine on intracellular pH, the parasite's cell cycle, and the induction of apoptosis. The effect of the alkyl-lysophospholipids was combined with that of inhibitors of some pumps and exchange regulators of intracellular pH (Na+/ H+; Cl-/CO- 3; and the Na+/K+ ATPase). The effect of the 3 alkyl-lysophospholipids on intracellular pH was indirect; the primary action occurred in the parasite's cell membrane. To determine intracellular pH, we used flow cytometry for the macrophages and axenic amastigotes and spectrofluorometry for the promastigote forms. Apoptosis and the cell cycle were studied by flow cytometry. Treatment of the extracellular promastigote form of L. donovani with the 3 alkyl-lysophospholipids induced death by apoptosis, whereas in the infected cell they caused necrosis rather than apoptosis. Miltefosine and ilmofosine at doses of 38 microM caused G2/M cell cycle inhibition in L. donovani promastigotes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17152926     DOI: 10.1645/GE-632R1.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

Review 1.  Phospholipid and sphingolipid metabolism in Leishmania.

Authors:  Kai Zhang; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-12-23       Impact factor: 1.759

2.  Mechanisms of action of substituted β-amino alkanols on Leishmania donovani.

Authors:  María Ángeles Abengózar; Luis A Bustos; Raquel García-Hernández; Pilar Fernández de Palencia; Ricardo Escarcena; Santiago Castanys; Esther del Olmo; Francisco Gamarro; Arturo San Feliciano; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

3.  Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

Authors:  Maha M Eissa; Riham M El-Moslemany; Alyaa A Ramadan; Eglal I Amer; Mervat Z El-Azzouni; Labiba K El-Khordagui
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.